We're on a mission to help companies of all sizes identify the best locations, secure incentives, obtain development approvals and optimize energy strategies through Location Economics®.
BLS & Co. serves as location and incentives advisor to Roche, Swiss multinational healthcare leader, and its subsidiary Genentech, the South San Francisco-based biotechnology industry leader. Our engagements with Roche date back to 2012, supporting over $2.7 billion in announced investments.
BLS & Co. serves aslocation and incentives advisor to Roche, Swiss multinational healthcare company, and its subsidiary Genentech, the South San Francisco-based biotechnology industry leader. Our engagements with Roche date back to 2012 with four major projects announced as of 2026:
BLS & Co. utilizes an assortment of services – a process we call Location Economics® – to advise clients on location decisions. Discover our variety of offerings to help you navigate the complex decision making processes that occur when searching for a new location for your organization.
BLS & Co. specializes in a variety of industries and our dedicated team is compromised of experts in nearly all major categories.
At BLS & Co., we have executed wide variety of projects for our clients, which includes facilities such as headquarters, warehouses, and data centers.
Stay up to date with BLS & Co. by exploring our latest news and musings on the world of site selection and more.
We're proud to provide a few key resources to help get you started on your site selection journey.
Search our North American database for the right location for your company's HQ, R&D Facilities, and more.
Browse our regional resource guide for site selection in the U.S.
If your organization is confronting complex and sensitive location decisions, please reach out to schedule a confidential conversation.
Interested in a career opportunity with BLS & Co.? Click below to learn more about our growing team and view all current openings.
A person who recommends sites for multinational corporations put Eli Lilly and Co.'s choice of the Lehigh Valley in perspective Tuesday afternoon. "Only one site, only one place, survives the processing of thousands," said Jay Biggins, executive managing director of Biggins Lacy Shapiro & Co.
"The process involves analysis from the start. … It requires cooperation. It involves high emotion. There’s a lot of trust involved."
Basically, once you announce a $3.5 billion investment into a community, it's very, very difficult to take it back, he said. It was impressive how much everyone in the Lehigh Valley "was on the same page." "We've never seen a problem," Biggins said, "which is really amazing when you think of all the moving parts.”
Jay is the Executive Managing Director at Biggins Lacy Shapiro & Co., one of the most highly regarded site selection and incentives advisory firms in North America. BLS & Co. helps manage the complexities associated with finding optimal locations and securing incentives to support new ventures.
This piece explores how pharma’s next investment cycle may shift toward modernizing, repurposing and optimizing existing manufacturing capacity, creating new opportunities for companies and communities in the 2030s.
Drawing on BLS’s experience advising major pharmaceutical manufacturers, this piece explores how workforce capacity, site readiness, reliable utilities and public investment shaped location decisions during the U.S. pharma manufacturing boom.
Part one of our three part analysis of the life sciences industry examines how scientific innovation, tax reform, industrial policy and federal pricing and trade pressures converged to drive the wave of U.S. pharmaceutical manufacturing investment in the 2020s.
We're on a mission to help companies of all sizes identify the best locations, secure incentives, obtain development approvals and optimize energy strategies through Location Economics®.
BLS & Co. serves as location and incentives advisor to Roche, Swiss multinational healthcare leader, and its subsidiary Genentech, the South San Francisco-based biotechnology industry leader. Our engagements with Roche date back to 2012, supporting over $2.7 billion in announced investments.
BLS & Co. serves aslocation and incentives advisor to Roche, Swiss multinational healthcare company, and its subsidiary Genentech, the South San Francisco-based biotechnology industry leader. Our engagements with Roche date back to 2012 with four major projects announced as of 2026:
BLS & Co. utilizes an assortment of services – a process we call Location Economics® – to advise clients on location decisions. Discover our variety of offerings to help you navigate the complex decision making processes that occur when searching for a new location for your organization.
BLS & Co. specializes in a variety of industries and our dedicated team is compromised of experts in nearly all major categories.
At BLS & Co., we have executed wide variety of projects for our clients, which includes facilities such as headquarters, warehouses, and data centers.
Stay up to date with BLS & Co. by exploring our latest news and musings on the world of site selection and more.
We're proud to provide a few key resources to help get you started on your site selection journey.
Search our North American database for the right location for your company's HQ, R&D Facilities, and more.
Browse our regional resource guide for site selection in the U.S.
If your organization is confronting complex and sensitive location decisions, please reach out to schedule a confidential conversation.
Interested in a career opportunity with BLS & Co.? Click below to learn more about our growing team and view all current openings.